Tacrine and physostigmine block nicotinic receptors in Xenopus oocytes injected with Torpedo electroplaque membranes

European Journal of Pharmacology

Volumn 363, Issue 2-3, 1998, Pages 197-202

  Cantí, Carles ^a,b   Bodas, Elena ^a   Marsal, Jordi ^a   Solsona, Carles ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Cholinesterase inhibitor; Tacrine; Torpedo nicotinic acetylcholine receptor; Xenopus oocyte

Indexed keywords

ACETYLCHOLINE; NICOTINIC RECEPTOR; PHYSOSTIGMINE; TACRINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; NEUROSECRETION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; STOICHIOMETRY; TORPEDO; VOLTAGE CLAMP; XENOPUS;

ANIMALS; CELL MEMBRANE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; NICOTINIC ANTAGONISTS; OOCYTES; PHYSOSTIGMINE; RECEPTORS, NICOTINIC; TACRINE; TORPEDO; XENOPUS;

EID: 0032545384     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00793-6     Document Type: Article

References (32)

1. Buller A.L., White M.M. Altered patterns of N-linked glycosylation of the Torpedo acetylcholine receptor expressed in Xenopus oocytes. J. Membrane Biol. 115:1990;1179-1189.
2. í et al., 1994
3. Cantí C., Marti E., Marsal J., Solsona C. Tacrine-induced increase in the release of spontaneous high quantal content events in Torpedo electric organ. Br. J. Pharmacol. 112:1994;19-22.
4. Clarke P.B.S., Reuben M., El-bizri H. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Br. J. Pharmacol. 111:1994;695-702.
5. Domet M.A., Webb C.E., Wilson D.F. Impact of alpha-bungarotoxin on transmitter release at the neuromuscular junction of the rat. Neurosci. Lett. 199:1995;49-52.
6. + current. Eur. J. Pharmacol. 141:1987;153-157.
7. Flynn D.D., Mash D.C. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J. Pharmacol. Exp. Ther. 250:1989;573-581.
8. + channel blockers. J. Neurochem. 54:1990;1130-1135.
9. Gundersen C.B., Miledi R., Parker I. Messenger RNA from human brain induces drug and voltage-operated channels in Xenopus oocytes. Nature. 308:1984;421-424.
10. Kushner L., Lerma J., Bennett M.V.L., Zukin S. Using the Xenopus oocyte system for expression and cloning of neuroreceptors and channels. Methods in Neurosciences. 1:1989;3-28.
11. Locaiono R.E., Mitchelson F.J. Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;31-35.
12. Marchi M., Raitieri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of 'impaired' cholinergic presynaptic function. J. Neurochem. 67:1996;1974-1981.
13. - channels in Xenopus oocytes injected with Torpedo electroplaque membranes. Proc. Natl. Acad. Sci. USA. 92:1995;5224-5228.
14. Morales A., Aleu J., Ivorra I., Ferragut J.A., Gonzalez J.M., Miledi R. Incorporation of reconstituted acetylcholine receptors from Torpedo into the Xenopus oocyte membrane. Proc. Natl. Acad. Sci. USA. 92:1995;8468-8472.
15. Nilsson L., Adem A., Hardy J., Winblad B., Nordberg A. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? J. Neural Transm. 70:1987;357-368.
16. Osterrieder W. 9-amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels. Br. J. Pharmacol. 92:1987;521-525.
17. Rogawsky M.A. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142:1987;169-172.
18. A receptors in Xenopus oocytes injected with rat brain synaptosomes. J. Neurochem. 67:1996;2212-2214.
19. Shaw F.H., Bentley G.A. The pharmacology of some new anticholinesterases. Aust. J. Exp. Biol. Med. Sci. 31:1953;573-576.
20. Shaw K.P., Aracava Y., Akaike J., Daly J.W., Rickett D.L., Albuquerque E.X. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 28:1985;527-538.
21. Sherby S.M., Eldefrawi A.T., Albuquerque E.X., Eldefrawi M.E. Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor. Mol. Pharmacol. 27:1985;343-348.
22. Sivilotti L.G., Mcneil D.K., Lewis T.M., Nassar M.A., Schoepfer R., Colquhoun D. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J. Physiol. (London). 500.1:1997;123-138.
23. Sugawara, T., Ohta, T., Asano, T., Ito, S., Nakazato, Y., 1997. Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells. Eur. J. Pharmacol. 319, 123-13.
24. Summers, W.K., Majovsky, L.V., Marsh, G.M., Tachiki, K., Kling, A., 1988. Tacrine, back to the future? In: Giacobini, E., Becker, R. (Eds.), Current Research in Alzheimer Therapy, Taylor and Francis, New York, pp. 259-265.
25. Summers W.K., Tachiki K., Kling A. Tacrine in treatment of Alzheimer's disease. A clinical update and recent pharmacologic studies. Eur. Neurol. 29:1989;28-32.
26. Suzuki T., Nonaka H., Fujimoto K., Kawashima K. Tacrine increases stimulation-evoked acetylcholine release from rat hippocampal slices. Jpn. J. Pharmacol. 65:1994;337-342.
27. Thesleff S., Sellin L.C., Tagerud S. Tetrahydroaminoacridine (tacrine) stimulates neurosecretionn at mammalian motor endplates. Br. J. Pharmacol. 100:1990;487-490.
28. Tian L., Prior C., Dempster J., Marshall I.G. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J. Physiol. (London). 476:1994;517-529.
29. Wachtel R.E. Comparison of acetylcholinesterases and their effects on acetylcholine-activated ion channels. Anesthesiol. 72:1990;496-503.
30. Wachtel R.E. Physostigmine block of ion channels activated by acetylcholine in BC3H1 cells. Mol. Pharmacol. 44:1993;1051-1055.
31. Wonnacott S. Presynaptic nicotinic acetylcholine receptors. Trends Neurosci. 20:1997;92-98.
32. Yost C.S., Maestrone E. Clinical concentrations of edrophonium enhance desensitisation of the nicotinic acetylcholine receptor. Anesth. Analg. 78:1994;520-526.